Korean J Transplant.  2020 Dec;34(Supple 1):S106. 10.4285/ATW2020.PO-1151.

Therapeutic challenges of hepatic mucormycosis in a renal transplant recipient: a case report

Affiliations
  • 1Division of Transplantation Vascular Surgery, Department of Surgery, Korea University College of Medicine, Seoul, Korea
  • 2Division of Nephrology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea

Abstract

Background
Mucormycosis is a rare, highly lethal opportunistic fungal disease affecting immune-compromised patients. It accounts for about 2% of invasive fungal infections occurring within 1 year after solid organ transplantation. We report here a case of successful treatment for hepatic mucormycosis with abscess formation that occurred 2 months after kidney transplantation.
Methods
A 59-year-old woman who underwent a deceased donor kidney transplantation 2 months ago was hospitalized with abdominal pain and fever. She had thymoglobulin induction therapy and was on conventional maintenance immunosuppressive therapy to prevent rejection. There were no specific complications except delayed graft function after kidney transplantation. The computed tomography (CT) scan was performed, demonstrating a 7.7 cm-sized abscess in the S5/8 segment of the liver. Percutaneous drainage was performed, and the culture result from the drainage came out as Rhizopus microsporus.
Results
Liposomal amphotericin B was administered intravenously at a dose of 5 mg/kg daily, and serial CTs were performed. Since the antifungal agent was initiated, the size of the lesions continuously decreased down to 5.8 cm; however, there was no significant change thereafter. Accordingly, we decided to perform surgical resection for the lesion. Following approximately 3 months of antifungal therapy, the right anterior sectionectomy of the liver was performed. The antifungal agent was continuously used for 3 months after surgery. Kidney function was well preserved and there was no evidence of recurrences until 4 months after liver resection.
Conclusions
Optimal treatment strategies for mucormycosis in a renal transplant recipient have not yet been defined. In this case, even though, we were able to minimize the extent of liver resection by using an antifungal agent for a long period of time and successfully treat mucormycosis without damage of transplanted kidney. Early surgical intervention for the lesion could be a more valid option of treatment to shorten the duration of the disease and reduce medical expense.

Full Text Links
  • KJT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr